Methyclothiazide
Back to searchMolecule Structure
Scientific Name
Methyclothiazide
Description of the Drug
Methyclothiazide is a diuretic drug used to treat hypertension and edema caused by heart failure, renal conditions, treatment with corticosteroids, and estrogen therapy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00232
http://www.drugbank.ca/drugs/DB00232
Brand Name(s)
Aquatensen, Enduron, Methyclothiazide
Company Owner(s)
Usl Pharma Inc, Watson Laboratories Inc, Abbott Laboratories Pharmaceutical Products Div, Chartwell Rx Sciences Llc, Par Pharmaceutical Inc, Abbvie Inc, Ivax Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Medpointe Pharmaceuticals Medpointe Healthcare Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Thiazide-sensitive sodium-chloride cotransporter | SINGLE PROTEIN | INHIBITOR | CHEMBL1876 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL49396 |
PharmGKB | PA164748094 |
Human Metabolome Database | HMDB0014377 |
DrugBank | DB00232 |
PubChem: Thomson Pharma | 14828250 |
PubChem | 4121 |
Mcule | MCULE-4894694501 |
Nikkaji | J5.603K |
EPA CompTox Dashboard | DTXSID6023313 |
DrugCentral | 1759 |
ChemicalBook | CB6764591 |
Guide to Pharmacology | 7235 |
rxnorm | METHYCLOTHIAZIDE |
KEGG Ligand | C07765 |
ChEBI | 6847 |